Growth Factors of squalene Market
The global squalene market is experiencing robust growth, driven by its versatile applications in cosmetics, skincare, pharmaceuticals, and vaccines. Squalene is a naturally occurring organic compound primarily found in shark liver oil, but also present in smaller amounts in plant sources such as olive oil, wheat germ, and amaranth seeds. Chemically, it is a triterpene hydrocarbon (C30H50) valued for its moisturizing, anti-aging, and immune-boosting properties.
Market Size & Forecast
The global squalene market was valued at USD 185.03 million in 2025, projected to reach USD 202.91 million in 2026, and is expected to grow to USD 437.36 million by 2034, with a CAGR of 10.10% from 2026 to 2034. Europe dominated the market in 2025 with a 48.00% share, driven by its established cosmetic industry, sustainable sourcing initiatives, and growing adoption of plant-derived squalene alternatives.
Market Drivers
1. Growing Cosmetic and Skincare Applications: Squalene's excellent moisturizing properties, ability to enhance skin hydration, and anti-aging benefits drive its demand in the cosmetics sector. As consumers increasingly prioritize skincare and grooming, especially with rising disposable incomes, the demand for products containing squalene is rising. Plant-derived squalene, sourced from olives, sugarcane, or amaranth seeds, aligns with the trend toward natural and organic formulations.
2. Pharmaceutical Demand as Vaccine Adjuvant: Squalene is widely used as an adjuvant in vaccines to enhance immune responses. The COVID-19 pandemic highlighted its importance in vaccines, including those developed by Pfizer-BioNTech and Novavax. Ongoing research into its immunomodulatory effects further expands its pharmaceutical applications.
3. Sustainably Sourced Alternatives: Increasing consumer awareness regarding environmental sustainability and animal welfare is driving demand for plant-derived squalene. Companies are actively adopting sustainable sourcing and demonstrating corporate responsibility by shifting from shark liver oil to renewable plant sources.
Market Restraints
Environmental and Ethical Concerns: Traditional sourcing from shark liver oil raises sustainability and ethical issues. Overexploitation threatens shark populations and marine ecosystems, potentially limiting market growth. Additionally, unsustainable fishing practices often result in significant bycatch, adding to environmental concerns.
Market Segmentation
By Source:
- Animal-Derived: Largest segment with 55.42% share in 2026, primarily from shark liver oil, valued for its efficacy in skincare and pharmaceuticals.
- Plant-Derived: Fastest-growing segment due to sustainability trends and increasing ethical consumer demand.
- Biosynthetic: Emerging segment leveraging biotechnology for scalable, cruelty-free production.
By End-Use Industry:
- Cosmetics: Dominates with 70.51% share in 2026, driven by growing adoption in skincare formulations for moisturizing, anti-aging, and clean beauty solutions.
- Pharmaceuticals: Significant segment, largely due to squalene's role in vaccines and drug delivery systems.
- Food and Others: Niche applications for functional foods and nutraceuticals.
Regional Insights
- Europe: Largest market, USD 89.63 million in 2025, projected to maintain dominance through 2026 due to strong cosmetics and pharmaceutical sectors. UK market projected USD 13.67 billion and Germany USD 22.78 billion by 2026.
- North America: Strong demand in cosmetics, projected USD 35.15 billion by 2026.
- Asia Pacific: Rapid growth driven by pharmaceutical expansion and vaccine demand; Japan projected USD 5.82 billion, China USD 14.38 billion, India USD 13 billion by 2026.
- Latin America: Rich in plant-based resources, providing local sourcing opportunities.
- Middle East & Africa: Growing demand for sustainable, plant-based products in cosmetics and food sectors.
Key Industry Players
Prominent players include Amyris (U.S.), Sophim (France), Kishimoto Special Liver Oil Co. (Japan), Croda International (U.K.), Evonik Healthcare (Germany), and Aasha Biochem (India). Companies are focusing on sustainable sourcing, product development, and geographic expansion to strengthen market presence.
Recent Developments:
- Oct 2023: Sophim raised USD 21.5 million to double production in France and Spain.
- Oct 2023: Evonik launched GMP-quality plant-based squalene for pharmaceuticals.
- May 2023: Croda partnered with Amyris for biotechnology-derived squalene supply.
- Dec 2022: Evonik introduced amaranth oil-derived squalene as a shark-liver alternative.
Conclusion
The global squalene market is projected to grow from USD 185.03 million in 2025 to USD 437.36 million by 2034 at a CAGR of 10.10%. Growth is driven by rising demand in cosmetics, skincare, and pharmaceutical applications, coupled with a shift toward sustainable, plant-based sourcing. Europe leads the market, while Asia Pacific shows the fastest growth. With innovations in biosynthetic production and continued adoption in vaccines and anti-aging formulations, the squalene market is set for sustained expansion over the forecast period.
Segmentation By Source
- Animal
- Plant
- Biosynthetic
By End-Use Industry
- Cosmetics
- Food
- Pharmaceuticals
- Others
By Region
- North America (By Source, By End-Use Industry, By Country)
- U.S. (By End-Use Industry)
- Canada (By End-Use Industry)
- Europe (By Source, By End-Use Industry, By Country)
- Germany (By End-Use Industry)
- U.K. (By End-Use Industry)
- France (By End-Use Industry)
- Italy (By End-Use Industry)
- Rest of Europe (By End-Use Industry)
- Asia Pacific (By Source, By End-Use Industry, By Country)
- China (By End-Use Industry)
- Japan (By End-Use Industry)
- India (By End-Use Industry)
- South Korea (By End-Use Industry)
- Rest of Asia Pacific (By End-Use Industry)
- Latin America (By Source, By End-Use Industry, By Country)
- Brazil (By End-Use Industry)
- Mexico (By End-Use Industry)
- Rest of Latin America (By End-Use Industry)
- Middle East & Africa (By Source, By End-Use Industry, By Sub-Region)
- Saudi Arabia (By End-Use Industry)
- South Africa (By End-Use Industry)
- Rest of the Middle East & Africa (By End-Use Industry)